Anlon Healthcare Files Draft Papers For IPO; Details Here

Healthcare company Anlon Healthcare Ltd. filed its preliminary papers for its initial public offering on Dec. 26. The IPO is a fresh issue of 1.40 crore shares. The expected launch date of the offer is yet to be announced.

Promoters of the company include Punitkumar R Rasadia, Meet Atulkumar Vachhani and Mamata Punitkumar Rasadia.

Interactive Financial Services Ltd. is the banker handling the issue, while KFin Technologies Ltd. is the main registrar.

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of high purity advance pharmaceutical intermediates serving as raw material or key starting material in the manufacturing of active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of tablet, capsules, ointment, syrup and more, ingredients in nutraceuticals formulations, personal care products and animal health products.

Their products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Our active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards.

Anlon Healthcare's listed peers include Kronox Lab Sciences Ltd., Ami Organics Ltd., and Supriya Lifescience Ltd.

For the quarter ended June, Anlon Healthcare clocked a net profit of Rs 4.54 crore against revenue of Rs 37.83 crore. The company's bottom-line print stood at Rs 9.66 crore for the fiscal ended March 2024, against a topline of Rs 66.58 crore. As of Nov. 30, 2024, the company's debt pile of secured loans stood at Rs 35.21 crore.

The company plans to utilise the proceeds from the fresh issue of shares for funding capital expenditure requirements for expansion of their manufacturing facility, repayment of borrowings availed by the company, funding working capital requirements, and for general corporate purposes.